Turnkey Interiors

Turnkey Interiors company information, Employees & Contact Information

Turnkey Interiors is a design and build company with a strong background in commercial office relocations and fit outs. Our core services include: - Consulting - Design concepts and detailed scope drawings - Custom designed feature elements - Space Planning - 3D Visualization and walkthroughs - On Site Construction - Material purchasing / procurement, delivery and Installations - Project Management - In house custom shop fitting and furniture manufacturing - Account and contract administration - Quality Control and Auditing - Contractors all Risk Insurance - Green Building Standards - Technology & Networking - Move Management - Risk mitigation & management - Security & Access Control - Audio Visual & Presentation - Branding & Signage - Test Fits, Building Selection - Building Renovations - Construction Services
Looking for a particular Turnkey Interiors employee's phone or email?

Turnkey Interiors Questions

News

Efficacy and Prognostic Analysis of Chemo-Immunotherapy After TKI Resistance in EGFR-Mutant Non-Small Cell Lung Cancer with TP53 or KRAS Co-Mutations - Frontiers

Efficacy and Prognostic Analysis of Chemo-Immunotherapy After TKI Resistance in EGFR-Mutant Non-Small Cell Lung Cancer with TP53 or KRAS Co-Mutations Frontiers

Non-invasive identification of TKI-resistant NSCLC: a multi-model AI approach for predicting EGFR/TP53 co-mutations - BMC Pulmonary Medicine

Non-invasive identification of TKI-resistant NSCLC: a multi-model AI approach for predicting EGFR/TP53 co-mutations BMC Pulmonary Medicine

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures - Nature

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures Nature

Increased expression of SSEA-4 on TKI-resistant non–small cell lung cancer with EGFR-T790M mutation - PNAS

Increased expression of SSEA-4 on TKI-resistant non–small cell lung cancer with EGFR-T790M mutation PNAS

Monitoring and treatment of cardiovascular complications during cancer therapies. Part II: Tyrosine kinase inhibitors - European Society of Cardiology

Monitoring and treatment of cardiovascular complications during cancer therapies. Part II: Tyrosine kinase inhibitors European Society of Cardiology

Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring - Wiley Online Library

Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring Wiley Online Library

How should we interpret conclusions of TKI-stopping studies - Leukemia - Nature

How should we interpret conclusions of TKI-stopping studies - Leukemia Nature

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations - Frontiers

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations Frontiers

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer - Journal of Hematology & Oncology

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer Journal of Hematology & Oncology

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial - Frontiers

Chinese Herbal Medicine Combined With EGFR-TKI in EGFR Mutation-Positive Advanced Pulmonary Adenocarcinoma (CATLA): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Frontiers

Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial - Nature

Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial Nature

Targeting HER3 to overcome EGFR TKI resistance in NSCLC - Frontiers

Targeting HER3 to overcome EGFR TKI resistance in NSCLC Frontiers

Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation - Nature

Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation Nature

TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis - Frontiers

TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis Frontiers

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer | Scientific Reports - Nature

Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer | Scientific Reports Nature

Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report - Frontiers

Remarkable response to third-generation EGFR-TKI plus crizotinib in a patient with pulmonary adenocarcinoma harboring EGFR and ROS1 co-mutation: a case report Frontiers

Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations - Nature

Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations Nature

SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer - Frontiers

SH-1028, An Irreversible Third-Generation EGFR TKI, Overcomes T790M-Mediated Resistance in Non-Small Cell Lung Cancer Frontiers

Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca2+ overload-induced ferroptosis - Frontiers

Natural product manoalide promotes EGFR-TKI sensitivity of lung cancer cells by KRAS-ERK pathway and mitochondrial Ca2+ overload-induced ferroptosis Frontiers

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - Frontiers

First-Generation EGFR-TKI Plus Chemotherapy Versus EGFR-TKI Alone as First-Line Treatment in Advanced NSCLC With EGFR Activating Mutation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Frontiers

Tokyo International makes Singapore debut with SE Asia in its sights - | Asian Legal Business

Tokyo International makes Singapore debut with SE Asia in its sights | Asian Legal Business

2025 AKC Trick Dog National Virtual Competition - American Kennel Club

2025 AKC Trick Dog National Virtual Competition American Kennel Club

Top Turnkey Interiors Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant